The American multinational pharmaceutical company Pzifer on Wednesday finalized its emergency use request with the United States Food and Drug Administration (FDA) to administer its COVID-19 vaccine to children under the age of 5.
Pfizer said its vaccine called “Pfizer-BioNTech COVID-19 vaccine” is 80% effective against symptomatic COVID-19 for young children.
“Pfizer and BioNTech have completed an ongoing application to the United States Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 vaccine for children 6 months to 4 years old (also referred to as 6 months to under 5 years old) on June 1, 2022,” the company said in a statement.
Children under 5 are the last to get vaccinated, but this also requires safety measures to be in place as this is a very sensitive target age group.
“We recognize that parents are eager to get their young children vaccinated against COVID-19 and while the FDA cannot predict how long its evaluation of the data and information will take, we will review any EUA requests we receive. as quickly as possible using a science-based approach,” the FDA said.
According to a Kaiser Family Foundation poll, many parents are hesitant to vaccinate their children as young as 5, with 27% saying they “definitely won’t” vaccinate their children in this age group. age. Only 18% plan to have their children vaccinated right away, while 38% say they would like to wait and see before deciding.
[ With inputs from agencies]
You can now write for sion5ews.com and be part of the community. Share your stories and opinions with us here.
#Pfizer #seeks #FDA #approval #covid #vaccine #children
Post expires at 10:29am on Sunday June 12th, 2022